 |
|
|
|
|
|
|
|
 |
 |
|
|
| |
|
|
Name: |
|
Oncolys Biopharma Inc. |
|
|
Incorporated: |
|
March 18, 2004 |
|
|
Location: |
|
| -Headquarters |
: |
3-16-33 Roppongi, Minato-ku,
Tokyo 106-0032, Japan |
|
|
|
|
|
|
|
|
|
-Okayama
Research Site |
: |
Center for Gene and Cell Therapy
Okayama University Hospital
2-5-1 Shikata-cho, Okayama
700-8558, JAPAN
|
|
|
|
|
|
|
|
Phone |
: |
+81-86-235-7997 |
|
|
Fax |
: |
+81-86-235-7884 |
|
|
|
|
-Kobe
Research Center |
: |
Biomedical Research Activities CPC-3F
1-5-5 Minatojima-minamimachi, Chuo-ku,
Kobe 650-0047, Japan |
| |
|
|
|
Phone |
: |
+81-78-303-1380 |
|
|
Fax |
: |
+81-78-303-1381 |
|
|
|
|
URL: |
|
www.oncolys.com |
|
|
Fund Raised: |
|
4,081,700,000yen |
|
|
Major banks: |
|
Sumitomo Mitsui Banking corporation
Bank of Tokyo-Mitsubishi UFJ |
|
|
CEO: |
|
Yasuo Urata, M.Sc. |
|
|
Board of Directors: |
|
| Yasunari Kashihara,M.Sc.M.B.A |
|
| Yasushi Rokutanda |
|
|
| Katsuyuki Nagai, Ph.D. (Former JT Pharmaceutical) |
|
| Noriaki Tanaka, M.D., Prof., (Okayama University) |
|
Toshiyoshi Fujiwara, M.D.,
(Center for Gene and Cell Therapy, Okayama University) |
|
|
|
Auditor: |
|
| Yasunori Suzuki |
|
| Kimio Kodama (Lawyer) |
|
| Shiro Oki (General Manager of Fuji Chemical Industry, Co. Ltd.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Copyright
(c)2004-2005, Oncolys BioPharma Inc. All rights reserved.
|
|
